Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) Price to Earnings (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' (ARCT) Price to Earnings was 6.87 for Q3 2023, down 27.6% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Price to Earnings (2022 - 2023) Analysis & Trends

For FY2022, Price to Earnings at Arcturus Therapeutics Holdings was 48.17.

  • Five-year quarterly Price to Earnings spans a low of 5.72 in Q1 2023 and a high of 48.17 in Q4 2022.
  • Per Business Quant data, the three quarters before Q3 2023 came in at 9.49 (Q2 2023), 5.72 (Q1 2023) and 48.17 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 6.87
Jun 30, 2023 9.49
Mar 31, 2023 5.72
Dec 31, 2022 48.17
API Access

Arcturus Therapeutics Holdings Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ARCT&period=max&api_key=YOUR_API_KEY